Search

everythinglearnresearchcommunity

for

Search:↓

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Suppressing certain hormones might help prevent prostate cancer.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

We need better ways to test and understand SARMs to make safer and more effective treatments.

The review suggests new ways to classify ejaculation problems and recommends different treatments based on the type of issue.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

A vaccine may prevent benign prostatic hyperplasia (BPH).

Large prostate links to more hair loss, but age of onset doesn't affect it.

Long-term diabetes is linked to lower prostate cancer risk.

Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.